Mazyar Shadman

Fred Hutchinson Cancer Research Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (14)

Christina Poh

Assistant Professor

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Chan Yoon Cheah

University of Western Australia

AUSTRALIA

View details

Jordan Gauthier

Assistant Professor

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Nancy Bartlett

Koman Professor of Medical Oncology in Medicine

Washington University in St. Louis

UNITED STATES

View details

Richard Burack

Professor

University of Rochester Medical Center

UNITED STATES

View details

David G. Coffey

Assistant Professor

University of Miami School of Medicine

UNITED STATES

View details

Natalie Grover

Assistant Professor

University of North Carolina at Chapel Hill School of Medicine

UNITED STATES

View details

Brian Till

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Arash Ash Alizadeh

Professor of Medicine

Stanford University School of Medicine

UNITED STATES

View details

Stephen Schuster

Robert and Margarita Louis-Dreyfus Professor in Chronic Lymphocytic Leukemia and Lymphoma Clinical Care and Research

Hospital of the University of Pennsylvania

UNITED STATES

View details

Matthew Matasar

Rutgers Cancer Institute of New Jersey

UNITED STATES

View details

Edus Warren

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Gareth Gregory

MONASH UNIVERSITY

AUSTRALIA

View details

Nausheen Ahmed

Assistant Professor

University of Kansas Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mazyar Shadman

Research Interests

Explore related searches

Contact this professor

Articles (20)

Pralatrexate is effective in cytotoxic cutaneous T-cell lymphomas

Real-world outcomes of brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma: a CIBMTR analysis

The impact of CMV reactivation on mortality after chimeric antigen receptor T-cell therapy

Maintenance therapy with romidepsin after autologous stem-cell transplant for peripheral T-cell lymphoma

Zanubrutinib is well tolerated and effective in patients with CLL/SLL intolerant of ibrutinib/acalabrutinib: updated results

How I treat patients with CLL after prior treatment with a covalent BTK inhibitor and a BCL-2 inhibitor

Zanubrutinib and Venetoclax for Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With and Without Del(17p)/ TP53 Mutation: SEQUOIA Arm D Results

Comparative efficacy of Bruton tyrosine kinase inhibitors in high-risk relapsed/refractory CLL: a network meta-analysis

Consensus in CLL: global needs matter

Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIA

Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma

Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma

Polatuzumab vedotin with infusional chemotherapy for untreated aggressive B-cell non-Hodgkin lymphomas

Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHL

Concurrent pembrolizumab with AVD for untreated classical Hodgkin lymphoma

Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL

Treatment outcomes with purine nucleoside analog alone or with rituximab for hairy cell leukemia at first relapse

Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission

A multicenter, retrospective study of accelerated venetoclax ramp‐up in patients with relapsed/refractory chronic lymphocytic leukemia

Heterologous SARS‐CoV‐2 vaccinations in patients with B‐cell lymphoid malignancies

Collaborators (14)

Christina Poh

Chan Yoon Cheah

Jordan Gauthier

Nancy Bartlett

Richard Burack

David G. Coffey

Natalie Grover

Brian Till

Arash Ash Alizadeh

Stephen Schuster

Matthew Matasar

Edus Warren

Gareth Gregory

Nausheen Ahmed

Make your next move.